PharmaCyte Biotech, Inc. (PMCB)
NASDAQ: PMCB · Real-Time Price · USD
0.8044
-0.1462 (-15.38%)
At close: May 15, 2026, 4:00 PM EDT
0.8100
+0.0056 (0.70%)
Pre-market: May 18, 2026, 5:52 AM EDT
PharmaCyte Biotech Market Cap
PharmaCyte Biotech has a market cap or net worth of $8.64 million as of May 18, 2026. Its market cap has increased by 7.95% in one year.
Market Cap
8.64M
Enterprise Value
-11.90M
1-Year Change
7.95%
Ranking
Category
Stock Price
$0.80
Market Cap Chart
Since January 2, 2013, PharmaCyte Biotech's market cap has decreased from $17.00M to $8.64M, a decrease of -49.20%. That is a compound annual growth rate of -4.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 8.60M | 17.81% |
| Dec 31, 2025 | 7.30M | -33.03% |
| Dec 31, 2024 | 10.90M | -41.40% |
| Dec 29, 2023 | 18.60M | -66.12% |
| Dec 30, 2022 | 54.90M | 5.98% |
| Dec 31, 2021 | 51.80M | 219.75% |
| Dec 31, 2020 | 16.20M | -72.16% |
| Dec 31, 2019 | 58.20M | 35.03% |
| Dec 31, 2018 | 43.10M | -23.17% |
| Dec 29, 2017 | 56.10M | -57.11% |
| Dec 30, 2016 | 130.80M | 266.39% |
| Dec 31, 2015 | 35.70M | -72.56% |
| Dec 31, 2014 | 130.10M | 108.16% |
| Dec 31, 2013 | 62.50M | 267.65% |
| Jan 2, 2013 | 17.00M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PMGC Holdings | 9.45M |
| Lunai Bioworks | 9.33M |
| Bolt Biotherapeutics | 9.19M |
| NuCana | 9.07M |
| Genprex | 8.65M |
| Curanex Pharmaceuticals | 8.52M |
| CDT Equity | 8.38M |
| Creative Medical Technology Holdings | 8.28M |